Successful Management of Neonatal and Infantile Kaposiform Hemangioendothelioma with Low-Dose Sirolimus Therapy

Sirolimus is reportedly effective for kaposiform hemangioendothelioma. However, data on the efficacy of low-dose sirolimus therapy remain limited. This report presents two cases of neonatal and infantile kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon successfully treated...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yoshimasa Uematsu, MD, Ken-ichiro Konishi, MD, PhD, Kiyoshi Tanaka, MD, PhD, Hajime Takayasu, MD, PhD, Eiichiro Watanabe, MD, PhD, Takuji Tomari, MD, Hitoshi Isohata, MD, Hidehiko Nakanishi, MD. PhD, Daigo Ochiai, MD, PhD, Yusuke Kumamoto, MD, PhD
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-09-01
סדרה:	Journal of Pediatrics: Clinical Practice
נושאים:	kaposiform hemangioendothelioma Kasabach-Merritt phenomenon neonatal serum level sirolimus
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2950541025000237
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!